Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women
In: Beneficial MicrobesLMU – Ludwig-Maximilians-Universität München, Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, University of Munich Medical Centre, Lindwurmstrasse 4, 80337 Munich, Germany.
Search for other papers by B. Pastor-Villaescusa in
Current site
Google Scholar
Search for other papers by J.A. Hurtado in
Current site
Google Scholar
CIBEROBN, (Physiopathology of Obesity and Nutrition CB12/03/30038), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.
Search for other papers by M. Gil-Campos in
Current site
Google Scholar
Search for other papers by J. Uberos in
Current site
Google Scholar
Search for other papers by J.A. Maldonado-Lobón in
Current site
Google Scholar
Search for other papers by M.P. Díaz-Ropero in
Current site
Google Scholar
Search for other papers by O. Bañuelos in
Current site
Google Scholar
Search for other papers by J. Fonollá in
Current site
Google Scholar
Search for other papers by M. Olivares in
Current site
Google Scholar
Search for other papers by the PROLAC Group in
Current site
Google Scholar
The breast milk microbiota has been described as a source of bacteria for infant gut colonisation. We studied the effect of Lactobacillus fermentum CECT5716 (Lc40) on growth and infection incidence of the infants, when the probiotic is administrated to the mothers. Moreover, whether such effects might depend on the interaction between the mother or infant microbiota and the probiotic administration. A total of 291 mother-infant pairs were studied for 16 weeks in a randomised double-blinded placebo-controlled multicentre trial. The Lc40 group (n=139) received 1 capsule/day containing 3×109 cfu Lc40; the control group (n=152) received 1 placebo (maltodextrin) capsule/day. A positive and significant correlation of the Staphylococcus load between breast milk and infant faeces was only observed in control group. Additionally, the weight z-score of the infants whose mothers had higher values of Lactobacillus in their breast milk were significantly higher for the Lc40 group. We observed a significant lower incidence of conjunctivitis in the infants whose mothers received Lc40. A higher load of Staphylococcus in infant faeces significantly increased the risk of respiratory infections. Such incidence, under an absent or low Staphylococcus load in the faeces, was significantly 36 times higher in the infants in the control group than in the infants in the Lc40 group. However, the protective effect of Lc40 was gradually reduced as the Staphylococcus load of the milk increased. The administration of Lc40 to nursing women might influence infant growth and health but it seems to depend on its interactions with mother or infant microbiota. Registered in the US Library of Medicine (www.clinicaltrials.gov): NCT02203877.
-
Ahrné, S., Lönnermark, E., Wold, A.E., Åberg, N., Hesselmar, B., Saalman, R., Strannegård, I.L., Molin, G. and Adlerberth, I., 2005. Lactobacilli in the intestinal microbiota of Swedish infants. Microbes and Infection 7: 1256-1262. https://doi.org/10.1016/j.micinf.2005.04.011
-
American Academy of Pediatrics, 2012. Breastfeeding and the use of human milk. Pediatrics 129: e827-e841. https://doi.org/10.1542/peds.2011-3552
-
Anders, K.L., Nguyen, H.L., Nguyen, N.M., Van Thuy, N.T., Hong Van, N.T., Hieu, N.T., Hong Tham, N.T., Thanh Ha, P.T., Lien, L.B., Vinh Chau, N. Van, Ty Hang, V.T., Van Doorn, H.R. and Simmons, C.P., 2015. Epidemiology and virology of acute respiratory infections during the first year of life: a birth cohort study in Vietnam. Pediatric Infectious Disease Journal 34: 361-70. https://doi.org/10.1097/INF.0000000000000643
-
Arroyo, R., Martín, V., Maldonado, A., Jiménez, E., Fernández, L. and Rodríguez, J.M., 2010. Treatment of infectious mastitis during lactation: antibiotics versus oral administration of lactobacilli isolated from breast milk. Clinical Infectious Diseases 50: 1551-1558. https://doi.org/10.1086/652763
-
Azari, A.A. and Barney, N.P., 2013. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 310: 1721-1729. https://doi.org/10.1001/jama.2013.280318
-
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., Khan, M.T., Zhang, J., Li, J., Xiao, L., Al-Aama, J., Zhang, D., Lee, Y.S., Kotowska, D., Colding, C., Tremaroli, V., Yin, Y., Bergman, S., Xu, X., Madsen, L., Kristiansen, K., Dahlgren, J. and Jun, W., 2015. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host and Microbe 17: 690-703. https://doi.org/10.1016/j.chom.2015.04.004
-
Baldassarre, M.E., Di Mauro, A., Mastromarino, P., Fanelli, M., Martinelli, D., Urbano, F., Capobianco, D. and Laforgia, N., 2016. Administration of a multi-strain probiotic product to women in the perinatal period differentially affects the breast milk cytokine profile and may have beneficial effects on neonatal gastrointestinal functional symptoms. A randomized clinical trial. Nutrients 8: 677 https://doi.org/10.3390/nu8110677
-
Bergmann, H., Rodríguez, J.M., Salminen, S. and Szajewska, H., 2014. Probiotics in human milk and probiotic supplementation in infant nutrition: a workshop report. British Journal of Nutrition 112: 1119-1128. https://doi.org/10.1017/S0007114514001949
-
Di Mauro, A., Neu, J., Riezzo, G., Raimondi, F., Martinelli, D., Francavilla, R. and Indrio, F., 2013. Gastrointestinal function development and microbiota. Italian Journal of Pediatrics 39: 15. https://doi.org/10.1186/1824-7288-39-15
-
Favier, C.F., Vaughan, E.E., De Vos, W.M. and Akkermans, A.D.L., 2002. Molecular monitoring of succession of bacterial communities in human neonates molecular monitoring of succession of bacterial communities in human neonates. Applied and Environmental Microbiology 68: 219-226. https://doi.org/10.1128/AEM.68.1.219
-
Fernández, L., Langa, S., Martín, V., Maldonado, A., Jiménez, E., Martín, R. and Rodríguez, J.M., 2013. The human milk microbiota: origin and potential roles in health and disease. Pharmacological Research 69: 1-10. https://doi.org/10.1016/j.phrs.2012.09.001
-
Gil-Campos, M., López, M.Á., Rodriguez-Benítez, M.V., Romero, J., Roncero, I., Linares, M.D., Maldonado, J., López-Huertas, E., Berwind, R., Ritzenthaler, K.L., Navas, V., Sierra, C., Sempere, L., Geerlings, A., Maldonado-Lobón, J.A., Valero, A.D., Lara-Villoslada, F. and Olivares, M., 2012. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: a randomized controlled trial. Pharmacological Research 65: 231-238. https://doi.org/10.1016/j.phrs.2011.11.016
-
Härtel, C., Pagel, J., Spiegler, J., Buma, J., Henneke, P., Zemlin, M., Viemann, D., Gille, C., Gehring, S., Frommhold, D., Rupp, J., Herting, E. and Göpel, W., 2017.Lactobacillus acidophilus/Bifidobacterium infantis probiotics are associated with increased growth of VLBWI among those exposed to antibiotics. Scientific Reports 7: 5633. https://doi.org/10.1038/s41598-017-06161-8
-
Hashemi, A., Villa, C.R. and Comelli, E.M., 2016. Probiotics in early life: a preventative and treatment approach. Food and Function 7: 1752-1768. https://doi.org/10.1039/c5fo01148e
-
Hurtado, J.A., Maldonado-Lobón, J.A., Díaz-Ropero, M.P., Flores-Rojas, K., Uberos, J., Leante, J.L., Affumicato, L., Couce, M.L., Garrido, J.M., Olivares, M., Fonollá, J. and the PROLAC Group, 2017. Oral administration to nursing women of Lactobacillus fermentum CECT5716 prevents lactational mastitis development: a randomized controlled trial. Breastfeeding Medicine 12: 202-209. https://doi.org/10.1089/bfm.2016.0173
-
Jost, T., Lacroix, C., Braegger, C.P., Rochat, F. and Chassard, C., 2014. Vertical mother-neonate transfer of maternal gut bacteria via breastfeeding. Environmental Microbiology 16: 2891-2904. https://doi.org/10.1111/1462-2920.12238
-
Lara-Villoslada, F., Sierra, S., Díaz-Ropero, M.P., Rodríguez, J.M., Xaus, J. and Olivares, M., 2009. Safety assessment of Lactobacillus fermentum CECT5716, a probiotic strain isolated from human milk. Journal of Dairy Research 76: 216-221. https://doi.org/10.1017/S0022029909004014
-
Maldonado, J., Cañabate, F., Sempere, L., Vela, F., Sánchez, A.R., Narbona, E., López-Huertas, E., Geerlings, A., Valero, A.D., Olivares, M. and Lara-Villoslada, F., 2012. Human milk probiotic Lactobacillus fermentum CECT5716 reduces the incidence of gastrointestinal and upper respiratory tract infections in infants. Journal of Pediatric Gastroenterology and Nutrition 54: 55-61. https://doi.org/10.1097/MPG.0b013e3182333f18
-
Maldonado-Lobón, J.A., Díaz-López, M.A., Carputo, R., Duarte, P., Díaz-Ropero, M.P., Valero, A.D., Sañudo, A., Sempere, L., Ruiz-López, M.D., Bañuelos, Ó., Fonollá, J. and Olivares Martín, M., 2015. Lactobacillus fermentum CECT 5716 reduces staphylococcus load in the breastmilk of lactating mothers suffering breast pain: a randomized controlled trial. Breastfeeding Medicine 10: 425-432. https://doi.org/10.1089/bfm.2015.0070
-
Mantaring, J., Benyacoub, J., Destura, R., Pecquet, S., Vidal, K., Volger, S. and Guinto, V., 2018. Effect of maternal supplement beverage with and without probiotics during pregnancy and lactation on maternal and infant health: a randomized controlled trial in the Philippines. BMC Pregnancy Childbirth 18: 193. https://doi.org/10.1186/s12884-018-1828-8
-
Markowiak, P. and Śliżewska, K., 2017. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9: 1021. https://doi:10.3390/nu9091021
-
Martín, R., Langa, S., Reviriego, C., Jimínez, E., Marín, M.L., Xaus, J., Fernández, L. and Rodríguez, J.M., 2003. Human milk is a source of lactic acid bacteria for the infant gut. Journal of Pediatrics 143: 754-758. https://doi.org/10.1016/j.jpeds.2003.09.028
-
Martín, R., Olivares, M., Marín, M.L., Fernández, L., Xaus, J. and Rodríguez, J.M., 2005. Probiotic potential of 3 lactobacilli strains isolated from breast milk. Journal of Human Lactation 21: 8-17. https://doi.org/10.1177/0890334404272393
-
Milani, C., Duranti, S., Bottacini, F., Casey, E., Turroni, F., Mahony, J., Belzer, C., Delgado Palacio, S., Arboleya Montes, S., Mancabelli, L., Lugli, G.A., Rodriguez, J.M., Bode, L., De Vos, W., Gueimonde, M., Margolles, A., Van Sinderen, D. and Ventura, M., 2017. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiology and Molecular Biology Reviews 81: e00036-17. https://doi.org/10.1128/MMBR.00036-17
-
O’Sullivan, A., Farver, M. and Smilowitz, J.T., 2015. The influence of early infant-feeding practices on the intestinal microbiome and body composition in infants. Nutrition and Metabolic Insights 8: NMI.S29530. https://doi.org/10.4137/NMI.S29530
-
Olivares, M., Díaz-Ropero, M.P., Sierra, S., Lara-Villoslada, F., Fonollá, J., Navas, M., Rodríguez, J.M. and Xaus, J., 2007. Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23: 254-260. https://doi.org/10.1016/j.nut.2007.01.004
-
Pannaraj, P.S., Li, F., Cerini, C., Bender, J.M., Yang, S., Rollie, A., Adisetiyo, H., Zabih, S., Lincez, P.J., Bittinger, K., Bailey, A., Bushman, F.D., Sleasman, J.W. and Aldrovandi, G.M., 2017. Association between breast milk bacterial communities and establishment and development of the infant gut microbiome. JAMA Pediatrics 171: 647-654. https://doi.org/10.1001/jamapediatrics.2017.0378
-
Patel, P.B., Diaz, M.C.G., Bennett, J.E. and Attia, M.W., 2007. Clinical features of bacterial conjunctivitis in children. Academic Emergency Medicine 14: 1-5. https://doi.org/10.1197/j.aem.2006.08.006
-
Prell, C. and Koletzko, B., 2016. Breastfeeding and complementary feeding. Deutsches Ärzteblatt International 113: 435-444. https://doi.org/10.3238/arztebl.2016.0435
-
Rautava, S., Luoto, R., Salminen, S. and Isolauri, E., 2012. Microbial contact during pregnancy, intestinal colonization and human disease. Nature Reviews Gastroenterology & Hepatology 9: 565-576. https://doi.org/10.1038/nrgastro.2012.144
-
Robertson, R.C., Manges, A.R., Finlay, B.B. and Prendergast, A.J., 2019. The human microbiome and child growth – first 1000 days and beyond. Trends in Microbiology 27: 131-147. https://doi.org/10.1016/j.tim.2018.09.008
-
Szajewska, H. and Chmielewska, A., 2013. Growth of infants fed formula supplemented with Bifidobacterium lactis Bb12 or Lactobacillus GG: a systematic review of randomized controlled trials. BMC Pediatrics 13: 185. https://doi.org/10.1186/1471-2431-13-185
-
Vendt, N., Grünberg, H., Tuure, T., Malminiemi, O., Wuolijoki, E., Tillmann, V., Sepp, E. and Korpela, R., 2006. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. Journal of Human Nutrition and Dietetics 19: 51-58. https://doi.org/10.1111/j.1365-277X.2006.00660.x
-
Watkins, C., Stanton, C., Ryan, C.A. and Ross, R.P., 2017. Microbial therapeutics designed for infant health. Frontiers in Nutrition 4: 48. https://doi.org/10.3389/fnut.2017.00048
-
Wessel, M.A., Cobb, J.C., Jackson, E.B., Harris, G.S. and Detwiler, A.C., 1954. Paroxysmal fussing in infancy, sometimes called colic. Pediatrics 14: 421-435.
'Paroxysmal fussing in infancy, sometimes called colic ' () 14 Pediatrics : 421 -435 .
-
Wopereis, H., Oozeer, R., Knipping, K., Belzer, C. and Knol, J., 2014. The first thousand days – intestinal microbiology of early life: establishing a symbiosis. Pediatric Allergy and Immunology 25: 428-438. https://doi.org/10.1111/pai.12232
-
World Health Organization (WHO), 2006. The WHO child growth standards. Available at: https://www.who.int/childgrowth/en/
-
World Health Organization (WHO), 2011. Exclusive breastfeeding for six months best for babies everywhere. Available at: https://www.who.int/mediacentre/news/statements/2011/breastfeeding_20110115/en/
-
World Health Organization (WHO), 2017. Diarrhoeal disease. Available at: https://www.who.int/news-room/fact-sheets/detail/diarrhoeal-disease
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 986 | 351 | 43 |
| PDF Views & Downloads | 1287 | 389 | 17 |
Effects of Lactobacillus fermentum CECT5716 Lc40 on infant growth and health: a randomised clinical trial in nursing women
In: Beneficial MicrobesLMU – Ludwig-Maximilians-Universität München, Division of Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, University of Munich Medical Centre, Lindwurmstrasse 4, 80337 Munich, Germany.
Search for other papers by B. Pastor-Villaescusa in
Current site
Google Scholar
PubMed
Search for other papers by J.A. Hurtado in
Current site
Google Scholar
PubMed
CIBEROBN, (Physiopathology of Obesity and Nutrition CB12/03/30038), Institute of Health Carlos III (ISCIII), 28029 Madrid, Spain.
Search for other papers by M. Gil-Campos in
Current site
Google Scholar
PubMed
Search for other papers by J. Uberos in
Current site
Google Scholar
PubMed
Search for other papers by J.A. Maldonado-Lobón in
Current site
Google Scholar
PubMed
Search for other papers by M.P. Díaz-Ropero in
Current site
Google Scholar
PubMed
Search for other papers by O. Bañuelos in
Current site
Google Scholar
PubMed
Search for other papers by J. Fonollá in
Current site
Google Scholar
PubMed
Search for other papers by M. Olivares in
Current site
Google Scholar
PubMed
Search for other papers by the PROLAC Group in
Current site
Google Scholar
PubMed
The breast milk microbiota has been described as a source of bacteria for infant gut colonisation. We studied the effect of Lactobacillus fermentum CECT5716 (Lc40) on growth and infection incidence of the infants, when the probiotic is administrated to the mothers. Moreover, whether such effects might depend on the interaction between the mother or infant microbiota and the probiotic administration. A total of 291 mother-infant pairs were studied for 16 weeks in a randomised double-blinded placebo-controlled multicentre trial. The Lc40 group (n=139) received 1 capsule/day containing 3×109 cfu Lc40; the control group (n=152) received 1 placebo (maltodextrin) capsule/day. A positive and significant correlation of the Staphylococcus load between breast milk and infant faeces was only observed in control group. Additionally, the weight z-score of the infants whose mothers had higher values of Lactobacillus in their breast milk were significantly higher for the Lc40 group. We observed a significant lower incidence of conjunctivitis in the infants whose mothers received Lc40. A higher load of Staphylococcus in infant faeces significantly increased the risk of respiratory infections. Such incidence, under an absent or low Staphylococcus load in the faeces, was significantly 36 times higher in the infants in the control group than in the infants in the Lc40 group. However, the protective effect of Lc40 was gradually reduced as the Staphylococcus load of the milk increased. The administration of Lc40 to nursing women might influence infant growth and health but it seems to depend on its interactions with mother or infant microbiota. Registered in the US Library of Medicine (www.clinicaltrials.gov): NCT02203877.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 0 | 0 | 0 |
| Full Text Views | 986 | 351 | 43 |
| PDF Views & Downloads | 1287 | 389 | 17 |
